Summary: The FDA has approved Avadel Pharmaceuticals’ LUMRYZ for pediatric patients aged 7 and older with narcolepsy, offering a once-nightly treatment for cataplexy and excessive daytime sleepiness. Key Takeaways: FDA Approval for Pediatric Use: LUMRYZ, previously approved for … [Read more...]
Collaboration Aims to Improve Access to Pediatric Sleep Assessment
Summary: Software as a Medical Device maker SleepImage and Gabi SmartCare, a maker of a home-based monitoring platform for children, have entered into a collaboration to improve access to pediatric sleep assessments. Their partnership aims to use Gabi’s FDA-cleared monitoring … [Read more...]
Study to Explore At-Home Sleep EEG in Pediatric Developmental Disorders
Summary: Beacon Biosignals has launched the HEADFIRST study to assess the usability of the Dreem headband for at-home EEG monitoring in pediatric patients with neurodevelopmental disorders, specifically children with Lennox-Gastaut Syndrome. The study aims to evaluate the … [Read more...]
Getting a Good Night’s Rest Is Vital for Neurodiverse Children – Pediatric Sleep Experts Explain Why
By Beth Ann Malow, Vanderbilt University Susan Nehiley Brasher, Emory University, and Terry Katz, University of Colorado Anschutz Professional medical Campus Most of us are all also acquainted with the outcomes of a poor night’s snooze – be it interrupted rest or simply too minor … [Read more...]
Health Canada Approves Wakix for Pediatric Narcolepsy Patients
Wakix is the 1st Well being Canada-approved cure for youngsters 6 decades of age and older suffering from excessive daytime sleepiness or cataplexy indicators connected with narcolepsy. Paladin Labs Inc, a subsidiary of Endo International plc, announced Overall health Canada’s … [Read more...]